(VIANEWS) - Palomar Holdings (PLMR), Opera Limited (OPRA), Horizon Therapeutics (HZNP) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Palomar Holdings (PLMR)
42% sales growth and 3.04% return on equity
Palomar Holdings, Inc., an insurance holding company, provides specialty property insurance to residential and commercial customers.
Palomar Holdings's sales growth this year is anticipated to be 45.2% and 29.3% for next year.
Year-on-year quarterly revenue growth grew by 33.8%, now sitting on 194.25M for the twelve trailing months.
Volume
Today's last reported volume for Palomar Holdings is 83675 which is 16.08% below its average volume of 99712.
Palomar Holdings's sales growth for the next quarter is 42%. The company's growth estimates for the present quarter and the next is 176.7% and 1500%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.04%.
Volatility
Palomar Holdings's last day, last week, and last month's current intraday variation average was 2.58%, 2.12%, and 2.05%, respectively.
Palomar Holdings's highest amplitude of average volatility was 5.71% (day), 3.55% (last week), and 3.74% (last month), respectively.
Palomar Holdings's Stock Yearly Top and Bottom Value
Palomar Holdings's stock is valued at $85.80 at 00:22 EST, way under its 52-week high of $115.40 and way higher than its 52-week low of $61.01.
Palomar Holdings's Moving Average
Palomar Holdings's worth is above its 50-day moving average of $85.33 and higher than its 200-day moving average of $79.99.2. Opera Limited (OPRA)
37.5% sales growth and 8.25% return on equity
Opera Limited, together with its subsidiaries, provides mobile and PC web browsers.
Opera Limited's sales growth this year is anticipated to be 48.8% and 17.4% for next year.
Year-on-year quarterly revenue growth grew by 8.5%, now sitting on 204.39M for the twelve trailing months.
Volume
Today's last reported volume for Opera Limited is 304726 which is 119.2% above its average volume of 139014.
Opera Limited's sales growth is a negative 0% for the present quarter and 37.5% for the next. The company's growth estimates for the current quarter and the next is a negative 100% and negative -73.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.25%.
Volatility
Opera Limited's last day, last week, and last month's current intraday variation average was 1.38%, 2.19%, and 2.55%, respectively.
Opera Limited's highest amplitude of average volatility was 3.24% (day), 4.81% (last week), and 5.45% (last month), respectively.
Opera Limited's Stock Yearly Top and Bottom Value
Opera Limited's stock is valued at $8.68 at 00:22 EST, way below its 52-week high of $13.93 and way higher than its 52-week low of $7.85.
Opera Limited's Moving Average
Opera Limited's value is under its 50-day moving average of $8.85 and way below its 200-day moving average of $10.21.3. Horizon Therapeutics (HZNP)
27.5% sales growth and 16.1% return on equity
Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.
Horizon Therapeutics's sales growth this year is expected to be 41.2% and 23.5% for next year.
Year-on-year quarterly revenue growth grew by 79.9%, now sitting on 2.56B for the twelve trailing months.
Volume
Today's last reported volume for Horizon Therapeutics is 935841 which is 32.09% below its average volume of 1378200.
Horizon Therapeutics's sales growth for the next quarter is 27.5%. The company's growth estimates for the ongoing quarter and the next is a negative 11.5% and 10.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.1%.
Volatility
Horizon Therapeutics's last day, last week, and last month's current intraday variation average was 0.06%, 0.63%, and 1.16%, respectively.
Horizon Therapeutics's highest amplitude of average volatility was 2.47% (day), 2.57% (last week), and 3.09% (last month), respectively.
Horizon Therapeutics's Stock Yearly Top and Bottom Value
Horizon Therapeutics's stock is valued at $107.19 at 00:22 EST, way under its 52-week high of $120.54 and way higher than its 52-week low of $66.41.
Horizon Therapeutics's Moving Average
Horizon Therapeutics's worth is below its 50-day moving average of $112.87 and above its 200-day moving average of $101.95.4. Selective Insurance Group (SIGI)
22.9% sales growth and 16.25% return on equity
Selective Insurance Group, Inc., together with its subsidiaries, provides insurance products and services in the United States.
Selective Insurance Group's sales growth this year is expected to be 15.4% and 9.1% for next year.
Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 3.31B for the twelve trailing months.
Volume
Today's last reported volume for Selective Insurance Group is 123541 which is 27.25% below its average volume of 169825.
Selective Insurance Group's sales growth for the next quarter is 22.9%. The company's growth estimates for the present quarter and the next is a negative 23.9% and negative -21.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.25%.
Volatility
Selective Insurance Group's last day, last week, and last month's current intraday variation average was 0.47%, 1.30%, and 1.18%, respectively.
Selective Insurance Group's highest amplitude of average volatility was 1.24% (day), 2.44% (last week), and 3.21% (last month), respectively.
Selective Insurance Group's Stock Yearly Top and Bottom Value
Selective Insurance Group's stock is valued at $81.72 at 00:22 EST, way under its 52-week high of $91.46 and way higher than its 52-week low of $61.68.
Selective Insurance Group's Moving Average
Selective Insurance Group's value is higher than its 50-day moving average of $78.42 and above its 200-day moving average of $77.37.5. American Software (AMSWA)
9.3% sales growth and 9.38% return on equity
American Software, Inc. develops, markets, and supports a range of computer business application software products and services in the United States and internationally.
American Software's sales growth this year is expected to be 9.2% and 8.2% for next year.
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 116.73M for the twelve trailing months.
Volume
Today's last reported volume for American Software is 264381 which is 143.42% above its average volume of 108610.
American Software's sales growth is a negative 0% for the ongoing quarter and 9.3% for the next. The company's growth estimates for the ongoing quarter and the next is a negative 22.2% and negative -27.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.38%.
Volatility
American Software's last day, last week, and last month's current intraday variation average was 6.37%, 6.76%, and 2.77%, respectively.
American Software's highest amplitude of average volatility was 6.70% (day), 8.84% (last week), and 4.41% (last month), respectively.
American Software's Stock Yearly Top and Bottom Value
American Software's stock is valued at $23.40 at 00:22 EST, way below its 52-week high of $33.27 and way higher than its 52-week low of $15.74.
American Software's Moving Average
American Software's worth is way below its 50-day moving average of $27.31 and higher than its 200-day moving average of $22.95.6. Aon plc (AON)
5.4% sales growth and 51.83% return on equity
Aon plc, a professional services firm, provides advice and solutions to clients focused on risk, retirement, and health worldwide.
Aon plc's sales growth this year is anticipated to be 9.7% and 5.3% for next year.
Year-on-year quarterly revenue growth grew by 15.6%, now sitting on 11.76B for the twelve trailing months.
Volume
Today's last reported volume for Aon plc is 1280730 which is 1.88% above its average volume of 1257040.
Aon plc's sales growth for the next quarter is 5.4%. The company's growth estimates for the ongoing quarter and the next is 10.5% and 29.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 51.83%.
Volatility
Aon plc's last day, last week, and last month's current intraday variation average was 1.02%, 0.55%, and 1.10%, respectively.
Aon plc's highest amplitude of average volatility was 1.53% (day), 1.67% (last week), and 2.28% (last month), respectively.
Aon plc's Stock Yearly Top and Bottom Value
Aon plc's stock is valued at $294.83 at 00:22 EST, under its 52-week high of $326.25 and way above its 52-week low of $197.86.
Aon plc's Moving Average
Aon plc's value is below its 50-day moving average of $301.69 and higher than its 200-day moving average of $268.78.7. UNITIL Corporation (UTL)
5.2% sales growth and 9.03% return on equity
Unitil Corporation, a public utility holding company, engages in the distribution of electricity and natural gas.
UNITIL Corporation's sales growth this year is expected to be 8% and 5% for next year.
Year-on-year quarterly revenue growth grew by 15.1%, now sitting on 439.7M for the twelve trailing months.
Volume
Today's last reported volume for UNITIL Corporation is 42986 which is 28.87% below its average volume of 60436.
UNITIL Corporation's sales growth for the next quarter is 5.2%. The company's growth estimates for the present quarter and the next is 500% and negative -4.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.03%.
Volatility
UNITIL Corporation's last day, last week, and last month's current intraday variation average was 0.69%, 0.72%, and 0.92%, respectively.
UNITIL Corporation's highest amplitude of average volatility was 1.57% (day), 2.32% (last week), and 2.34% (last month), respectively.
UNITIL Corporation's Stock Yearly Top and Bottom Value
UNITIL Corporation's stock is valued at $41.30 at 00:22 EST, way under its 52-week high of $59.32 and higher than its 52-week low of $38.02.
UNITIL Corporation's Moving Average
UNITIL Corporation's worth is below its 50-day moving average of $43.46 and way below its 200-day moving average of $48.92.8. Gildan Activewear (GIL)
5.1% sales growth and 22.95% return on equity
Gildan Activewear Inc. manufactures and sells a range of apparel products in North America, Europe, the Asia-Pacific, and Latin America.
Gildan Activewear's sales growth this year is expected to be 39.5% and 6.4% for next year.
Year-on-year quarterly revenue growth grew by 225.3%, now sitting on 2.63B for the twelve trailing months.
Volume
Today's last reported volume for Gildan Activewear is 313674 which is 44.22% below its average volume of 562387.
Gildan Activewear's sales growth for the next quarter is 5.1%. The company's growth estimates for the present quarter and the next is 83.3% and 17.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.95%.
Volatility
Gildan Activewear's last day, last week, and last month's current intraday variation average was 1.03%, 0.90%, and 1.32%, respectively.
Gildan Activewear's highest amplitude of average volatility was 1.79% (day), 1.60% (last week), and 2.23% (last month), respectively.
Gildan Activewear's Stock Yearly Top and Bottom Value
Gildan Activewear's stock is valued at $42.38 at 00:22 EST, below its 52-week high of $43.63 and way above its 52-week low of $24.81.